Exploring New Horizons: A Novel Cdk5 Inhibitor Restoring Cognitive Function and Alleviating Type 2 Diabetes
Authors:
- Sangita PaulSPSangita Paul
- K.V. DileepKDK.V. Dileep
- S PoornimaSPS Poornima
- C SrinivasCSC Srinivas
- A.M. SajithASA.M. Sajith
- Bk BinukumarBBBk Binukumar
Preprint
Abstract
Type 2 diabetes (T2D) is a metabolic disorder frequently associated with cognitive decline, making T2D patients susceptible to dementia. Often referred to as type 3 diabetes, Alzheimer’s disease (AD) shares a close association with hyperglycemia and insulin dysregulation. Despite this, anti-diabetic medications have proven beneficial in reducing cognitive impairment induced by T2D. Previous research, including our own, has highlighted the dysregulation of Cdk5 activity in both T2D and AD, with downstream consequences contributing to the progression of pathophysiological changes in both disorders. Therefore, targeting the kinase Cdk5 may offer a more effective approach to treating T2D and cognitive deterioration. In our study, we present evidence supporting Cdk5 as a significant mediator between T2D and cognitive decline. Through the screening of the KINACore library, we identified novel brain-penetrant Cdk5 inhibitors, BLINK11 and BLINK15. Our study further validated the efficacy of these inhibitors in a high-fat diet-induced T2D model, demonstrating their rescue effects on T2D pathogenesis, including blood glucose levels, obesity, and cognitive impairment as assessed through behavioral studies. Notably, BLINK11 emerges as a promising Cdk5 inhibitor for improving the T2D phenotype and addressing cognitive impairment in T2D conditions. GraphicalKeywords
This publication has 53 references indexed in Scilit:
- Cdk5-mediated oligodendrocyte myelin breakdown and neuroinflammation: Implications for the link between Type 2 Diabetes and Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- Diabetes Mellitus2019
- The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice2018
- Structural insights of cyclin dependent kinases: Implications in design of selective inhibitorsEuropean Journal of Medicinal Chemistry, 2017
- Kinase hinge binding scaffolds and their hydrogen bond patternsBioorganic & Medicinal Chemistry, 2015
- The Role of Cdk5 in Alzheimer’s DiseaseMolecular Neurobiology, 2015
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Epik: a software program for pK a prediction and protonation state generation for drug-like moleculesJournal of Computer-Aided Molecular Design, 2007
- Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the ratJournal of Neuroscience Methods, 1985